WHO ICTRP trial
An Open-label, Multi-Center, Phase I/II Trial Investigating the Pharmacokinetic…
EUCTR2009-013317-10-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-013317-10-BE |
|---|---|
| Public title | An Open-label, Multi-Center, Phase I/II Trial Investigating the Pharmacokinetic profile of Zalutumumab, a Human Monoclonal Epidermal Growth Factor Receptor Antibody in non-curable patients with SCCHN - Zalutumumab PK in SCCHN |
| Scientific title | An Open-label, Multi-Center, Phase I/II Trial Investigating the Pharmacokinetic profile of Zalutumumab, a Human Monoclonal Epidermal Growth Factor Receptor Antibody in non-curable patients with SCCHN - Zalutumumab PK in SCCHN |
| Primary sponsor | Genmab A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Hungary;Slovakia;Belgium;United Kingdom |
| Conditions | Non-Curable Squamous cell carcinoma of the head and neck (SCCHN) MedDRA version: 12.0 Level: LLT Classification code 10060121 Term: Squamous cell carcinoma of head and neck |
| Interventions | Product Name: HuMax-EGFr (zalutumumab) Product Code: HuMax-EGFr Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: zalutumumab CAS Number: 667901-13-5 Current Sponsor code: HuMax-EGFr Concentration unit: mg/ml… |
| Registration date | Apr 9, 2009 |
| Target size | 26 |
| Secondary IDs | GEN211 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: